OSLO, Norway, Feb 22, 2017 /PRNewswire/ --
Nordic Nanovector ASA (OSE: NANO), a biopharmaceutical company focusing on the development and commercialisation of novel targeted therapeutics for haematological cancers, will announce its fourth quarter and full year 2016 results on...